by Bill Vick | Apr 16, 2020 | Pulmonary Fibrosis
We’ve heard that elderly people and those with underlying health conditions are most at risk if they’re infected with coronavirus, but those can seem like really general terms. Who does that include? And why can they face more serious illness?...
by Bill Vick | Apr 16, 2020 | Pulmonary Fibrosis
BEIJING, April 16, 2020 /PRNewswire/ — A news report by Science and Technology Daily: Is there any specific drug to fight against COVID-19? When can we get access to the specific drug? These two questions are hard to answer for now. Developing the specific drug...
by Bill Vick | Apr 16, 2020 | Pulmonary Fibrosis
(Galapagos) Gilead Sciences-partnered Belgium biotech Galapagos has a lot of shots on goal, with many being tied up with its multibillion dollar deal with Gilead. But Galapagos is still working on its future pipeline, seemingly not wanting to be bought up by its...
by Bill Vick | Apr 16, 2020 | Pulmonary Fibrosis
In this update, the Centers for Disease Control and Prevention (CDC) offers essential information for people at higher risk for severe illness due to COVID-19. *Please Note: This information is being shared directly from the CDC website . COVID-19 is a new disease and...
by Bill Vick | Apr 16, 2020 | Pulmonary Fibrosis
The fight goes on to rid the world of the COVID-19 coronavirus. And one Canadian company is on the forefront of the battle. And plans to help win it. Algernon Pharmaceuticals Inc. (AGN) ( CSE.AGN , OTCQB:AGNPF , Forum ), a clinical stage pharmaceutical development...
by Bill Vick | Apr 16, 2020 | Pulmonary Fibrosis
Two stem cell experts have found an abundance of abnormal stem cells in the lungs of patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), a leading cause of death worldwide. Frank McKeon, professor of biology and biochemistry and director of the Stem...
